Thermo Fisher Scientific (NYSE:TMO – Get Free Report) released its quarterly earnings results on Wednesday. The medical research company reported $5.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.13 by $0.24, Briefing.com reports. Thermo Fisher Scientific had a return on equity of 18.45% and a net margin of 14.20%. The company had revenue of $10.54 billion during the quarter, compared to the consensus estimate of $10.50 billion. During the same quarter in the prior year, the company posted $5.15 EPS. The firm’s revenue was down 1.4% on a year-over-year basis. Thermo Fisher Scientific updated its FY 2024 guidance to 21.290-22.070 EPS and its FY24 guidance to $21.29-22.07 EPS.
Thermo Fisher Scientific Trading Up 4.0 %
TMO traded up $23.16 during mid-day trading on Thursday, reaching $597.89. The stock had a trading volume of 2,468,688 shares, compared to its average volume of 1,548,302. The stock has a market capitalization of $228.23 billion, a P/E ratio of 38.64, a P/E/G ratio of 2.58 and a beta of 0.77. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.33 and a current ratio of 1.70. The firm’s fifty day simple moving average is $562.82 and its two-hundred day simple moving average is $564.99. Thermo Fisher Scientific has a 52 week low of $415.60 and a 52 week high of $603.82.
Thermo Fisher Scientific Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Friday, September 13th will be given a $0.39 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $1.56 dividend on an annualized basis and a yield of 0.26%. Thermo Fisher Scientific’s payout ratio is 10.01%.
Insider Buying and Selling at Thermo Fisher Scientific
Analyst Ratings Changes
Several analysts recently weighed in on the company. HSBC increased their target price on Thermo Fisher Scientific from $660.00 to $670.00 and gave the company a “buy” rating in a research note on Tuesday, April 30th. Raymond James increased their target price on Thermo Fisher Scientific from $650.00 to $660.00 and gave the stock an “outperform” rating in a report on Thursday. Barclays dropped their target price on Thermo Fisher Scientific from $615.00 to $600.00 and set an “equal weight” rating for the company in a report on Friday, June 28th. The Goldman Sachs Group increased their target price on Thermo Fisher Scientific from $550.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Finally, Evercore ISI dropped their target price on Thermo Fisher Scientific from $615.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $616.50.
Get Our Latest Stock Analysis on Thermo Fisher Scientific
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Recommended Stories
- Five stocks we like better than Thermo Fisher Scientific
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Why Invest in 5G? How to Invest in 5G Stocks
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Energy and Oil Stocks Explained
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.